Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritis. [PDF]
Brunner HI +20 more
europepmc +1 more source
EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's disease. [PDF]
Fautrel B +32 more
europepmc +1 more source
Efficacy and safety of tocilizumab in Chinese patients with systemic juvenile idiopathic arthritis: a multicentre phase IV trial. [PDF]
Li C +13 more
europepmc +1 more source
Clinical outcomes of tocilizumab therapy in polyarticular and systemic juvenile idiopathic arthritis: a single-center analysis (2018-2022). [PDF]
Gazda A +7 more
europepmc +1 more source
Efficacy and safety of canakinumab in systemic juvenile idiopathic arthritis, the first Chinese experience. [PDF]
Qiu L +7 more
europepmc +1 more source
Clinical characteristics and prognosis of interstitial lung disease in systemic juvenile idiopathic arthritis: a two-center retrospective observational cohort study. [PDF]
Zhan W +7 more
europepmc +1 more source
Canakinumab in the treatment of systemic juvenile idiopathic arthritis: a retrospective single center study in China. [PDF]
Zhu X +5 more
europepmc +1 more source
Diagnosing and Treating Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease as Part of the Still's Disease Continuum. [PDF]
Kontzias A +3 more
europepmc +1 more source
Systemic juvenile idiopathic arthritis-associated lung disease: A retrospective cohort study.
Belozerov KE +4 more
europepmc +1 more source

